XTX Topco Ltd - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 85 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$139,093
-7.5%
62,938
-21.7%
0.02%
-21.9%
Q4 2022$150,324
-6.6%
80,387
+28.6%
0.03%
-20.0%
Q3 2022$161,000
+360.0%
62,510
+243.1%
0.04%
+185.7%
Q2 2022$35,000
-66.7%
18,219
-48.4%
0.01%
-69.6%
Q1 2022$105,000
-11.8%
35,324
+33.6%
0.05%
-31.3%
Q4 2021$119,000
+65.3%
26,449
+77.3%
0.07%
+179.2%
Q3 2021$72,000
-33.9%
14,917
-3.3%
0.02%
-54.7%
Q1 2021$109,00015,4250.05%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 3,387,172$6,537,0001.72%
Worth Venture Partners, LLC 969,698$2,366,0001.39%
Omega Fund Management, LLC 1,971,241$3,804,0001.21%
Telemetry Investments, L.L.C. 495,000$955,0001.13%
CM Management, LLC 350,000$676,0000.72%
Bruce & Co., Inc. 1,557,312$3,005,0000.71%
Trellus Management Company, LLC 295,000$569,0000.69%
Abingworth LLP 1,041,131$1,999,0000.64%
1492 Capital Management LLC 489,376$944,0000.62%
GENERAL AMERICAN INVESTORS CO INC 1,752,470$3,382,0000.34%
View complete list of PARATEK PHARMACEUTICALS INC shareholders